Torrent Pharmaceuticals shares slipped nearly 8 percent on Tuesday after it reported a consolidated net loss of Rs 152 crore in March-quarter as compared to a consolidated profit of Rs 228 crore in the year-ago quarter.
NSE
The stock fell as much as 7.8 percent to hit the day's low of Rs 1,525 per share on the BSE. At 10:35 am, the stock was trading 4.3 percent lower at Rs 1,585 as compared to a 0.3 percent (123 points) rise in the BSE Sensex at 39,476.
Net loss of Rs 152 crore for the fourth quarter was on account of the one-time loss of Rs 357 crore. The consolidated revenue from operations stood at Rs 1,856 crore for Q4. It was Rs 1,708 crore for the same period a year ago.
The company’s consolidated total income rose 7 percent to Rs 1,873 crore from Rs 1,750 crore (YoY). EBITDA (earnings before interest, tax, depreciation, and amortization) margin was down 187 basis points (bps) at 25.5 percent on a sequential basis.
One basis point is a hundredth of a percentage point.
For FY19, the company posted a net profit of Rs 436 crore as against Rs 678 crore for the previous fiscal year. The company's board has declared a final dividend of Rs 4 per equity share, Torrent Pharmaceuticals said.
Also, track all live market action on CNBC-TV18 Market Blog
Disclaimer: CNBCTV18.com advises users to check with certified experts before taking any investment decisions